BRINTELLIX

Welcome to the Brand page for “BRINTELLIX”, which is offered here for Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, huntington's disease, insomnia, parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “BRINTELLIX” is believed to be currently owned by “H. Lundbeck A/S”.